Delivering the Thinking Healthy Programme as a universal group intervention integrated into routine antenatal care: a randomized-controlled pilot study.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
06 01 2023
Historique:
received: 05 09 2022
accepted: 26 12 2022
entrez: 5 1 2023
pubmed: 6 1 2023
medline: 10 1 2023
Statut: epublish

Résumé

Women with perinatal depression and their children are at increased risk of poor health outcomes. There is a need to implement non-stigmatizing interventions into existing health systems which reduce psychosocial distress during pregnancy and prevent perinatal depression. We adapted the WHO-endorsed Thinking Healthy Programme (THP) to be delivered universally to all women attending routine online pregnancy schools in Istanbul, Turkey. This study aimed to evaluate the feasibility and acceptability of this intervention. This mixed-methods study incorporated a two-arm pilot randomized controlled trial and qualitative evaluation of the feasibility and acceptability of the adapted THP - Brief Group version (THP-BGV) to a range of stakeholders. We recruited pregnant women at 12-30 weeks' gestation through pregnancy schools within the University Hospital's catchment area. Women in the intervention arm received five online sessions of the THP-BGV delivered by antenatal nurses. The intervention employed principles of cognitive behaviour therapy to provide psychoeducation, behaviour activation, problem-solving strategies and group support to participants. In the control arm, women received usual care consisting of routine online educational pregnancy classes aided by the antenatal nurses. The women were assessed for depressive symptoms with the Edinburgh Postnatal Depression Scale at baseline and 4-6 weeks post-intervention and also evaluated for anxiety, perceived social support, partner relationship, level of disability and sleep quality. In-depth interviews were conducted with women and other key stakeholders. Of the 99 consecutive women referred to the pregnancy schools, 91 (91.9%) were eligible and 88 (88.8%) consented to participate in the study and were randomized. Eighty-two (83%) completed the final assessments. Our main findings were that this preventive group intervention was feasible to be integrated into routine antenatal educational classes and it was valued by the women and delivery-agents. While the study was not powered to detect differences between intervention and control conditions, we found small trends towards reduction in anxiety and depressive symptoms favoring the intervention arm. No serious adverse events were reported. Given the paucity of preventive interventions for perinatal depression in low and middle-income countries, a fully powered definitive randomized controlled trial of this feasible and acceptable intervention should be conducted. The study was registered at Clinical Trails.gov ( NCT04819711 ) (Registration Date: 29/03/2021).

Sections du résumé

BACKGROUND
Women with perinatal depression and their children are at increased risk of poor health outcomes. There is a need to implement non-stigmatizing interventions into existing health systems which reduce psychosocial distress during pregnancy and prevent perinatal depression. We adapted the WHO-endorsed Thinking Healthy Programme (THP) to be delivered universally to all women attending routine online pregnancy schools in Istanbul, Turkey. This study aimed to evaluate the feasibility and acceptability of this intervention.
METHODS
This mixed-methods study incorporated a two-arm pilot randomized controlled trial and qualitative evaluation of the feasibility and acceptability of the adapted THP - Brief Group version (THP-BGV) to a range of stakeholders. We recruited pregnant women at 12-30 weeks' gestation through pregnancy schools within the University Hospital's catchment area. Women in the intervention arm received five online sessions of the THP-BGV delivered by antenatal nurses. The intervention employed principles of cognitive behaviour therapy to provide psychoeducation, behaviour activation, problem-solving strategies and group support to participants. In the control arm, women received usual care consisting of routine online educational pregnancy classes aided by the antenatal nurses. The women were assessed for depressive symptoms with the Edinburgh Postnatal Depression Scale at baseline and 4-6 weeks post-intervention and also evaluated for anxiety, perceived social support, partner relationship, level of disability and sleep quality. In-depth interviews were conducted with women and other key stakeholders.
RESULTS
Of the 99 consecutive women referred to the pregnancy schools, 91 (91.9%) were eligible and 88 (88.8%) consented to participate in the study and were randomized. Eighty-two (83%) completed the final assessments. Our main findings were that this preventive group intervention was feasible to be integrated into routine antenatal educational classes and it was valued by the women and delivery-agents. While the study was not powered to detect differences between intervention and control conditions, we found small trends towards reduction in anxiety and depressive symptoms favoring the intervention arm. No serious adverse events were reported.
CONCLUSIONS
Given the paucity of preventive interventions for perinatal depression in low and middle-income countries, a fully powered definitive randomized controlled trial of this feasible and acceptable intervention should be conducted.
TRIAL REGISTRATION
The study was registered at Clinical Trails.gov ( NCT04819711 ) (Registration Date: 29/03/2021).

Identifiants

pubmed: 36604685
doi: 10.1186/s12888-022-04499-6
pii: 10.1186/s12888-022-04499-6
pmc: PMC9816542
doi:

Banques de données

ClinicalTrials.gov
['NCT04819711']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14

Subventions

Organisme : Medical Research Council
ID : MR/T038616/1
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

J Affect Disord. 2021 Aug 1;291:294-306
pubmed: 34062397
Turk Psikiyatri Derg. 2018 Winter;29(4):248-257
pubmed: 30887475
Front Psychiatry. 2021 Nov 17;12:736790
pubmed: 34867528
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
JAMA. 2019 Feb 12;321(6):588-601
pubmed: 30747970
Evid Based Ment Health. 2021 Apr 26;:
pubmed: 33903119
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
J Med Internet Res. 2020 Feb 20;22(2):e16407
pubmed: 32130131
JAMA Psychiatry. 2013 May;70(5):490-8
pubmed: 23487258
Ment Health Fam Med. 2010 Dec;7(4):239-47
pubmed: 22477948
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Indian J Psychiatry. 2020 Jan;62(Suppl 2):S223-S229
pubmed: 32055065
Matern Child Health J. 2017 Mar;21(3):607-615
pubmed: 27485491
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
Br J Psychiatry. 2008 May;192(5):368-75
pubmed: 18450663
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Arch Womens Ment Health. 2020 Oct;23(5):699-707
pubmed: 32394399
BMC Psychiatry. 2017 Feb 23;17(1):79
pubmed: 28231791
Lancet Psychiatry. 2016 Oct;3(10):973-982
pubmed: 27650773
Health Policy Plan. 2010 Mar;25(2):104-11
pubmed: 19917651
Psychol Med. 2003 Oct;33(7):1161-7
pubmed: 14580070
Arch Womens Ment Health. 2015 Feb;18(1):41-60
pubmed: 25422150
PLoS One. 2009 Dec 17;4(12):e8343
pubmed: 20020047
Glob Ment Health (Camb). 2015;2:
pubmed: 28593049
PLoS One. 2021 Jun 25;16(6):e0253790
pubmed: 34170948
Int J Ment Health Syst. 2016 Mar 15;10:24
pubmed: 26985235
Psychol Med. 2021 Sep;51(12):2104-2116
pubmed: 32343221
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
J Midwifery Womens Health. 2017 Nov;62(6):723-736
pubmed: 29210501
BMC Womens Health. 2019 Apr 3;19(1):53
pubmed: 30943958
Lancet. 2008 Sep 13;372(9642):902-9
pubmed: 18790313
Br J Psychiatry. 2012 Mar;200(3):184-90
pubmed: 22383765
Prev Sci. 2018 Oct;19(7):977-986
pubmed: 30121876
J Pers Assess. 1990 Winter;55(3-4):610-7
pubmed: 2280326
Semin Perinatol. 2015 Aug;39(5):345-52
pubmed: 26164538
BMC Res Notes. 2020 Jul 28;13(1):355
pubmed: 32723389

Auteurs

Perran Boran (P)

Marmara University, School of Medicine, Division of Social Pediatrics, Istanbul, Turkey.

Melike Dönmez (M)

Marmara University, School of Medicine, Department of Psychiatry, Istanbul, Turkey.

Ezgi Barış (E)

Marmara University, School of Medicine, Division of Social Pediatrics, Istanbul, Turkey.
Marmara University, Institute of Health Sciences, Social Pediatrics Doctorate Program, Istanbul, Turkey.

Mahmut Caner Us (MC)

Marmara University, Institute of Health Sciences, Social Pediatrics Doctorate Program, Istanbul, Turkey.

Zeynep Meva Altaş (ZM)

Marmara University, School of Medicine, Department of Public Health, Istanbul, Turkey.

Anum Nisar (A)

School of Public Health, Xi'an Jiaotong University, Xi'an, China.

Najia Atif (N)

Human Development Research Foundation, Islamabad, Pakistan.

Siham Sikander (S)

Human Development Research Foundation, Islamabad, Pakistan.

Seyhan Hıdıroğlu (S)

Marmara University, School of Medicine, Department of Public Health, Istanbul, Turkey.

Dilşad Save (D)

Marmara University, School of Medicine, Department of Public Health, Istanbul, Turkey.

Atif Rahman (A)

University of Liverpool, Department of Primary Care and Mental Health, Waterhouse Buildings Block B, Liverpool, L69 3LH, UK. atifr@liverpool.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH